PharmRep Direct from the editors of Pharmaceutical Representative Visit www.PharmRep.com Today!

March 4th , 2010 Issue 39 Vol. 5
www.pharmrep.com  
Contact Editor: Reid Paul
PharmRep Direct News

Rethinking Sales Compensation, Again
Sales compensation practices are due for an overhaul in 2010
» MORE

At Risk from Substandard Meds
Recently, the public and policymakers have become more aware of the issue of counterfeit medicines, but scant attention has been paid to substandard drugs
» MORE

Astellas’ Hostile Takeover Turns Even More Hostile
The Japan-based company filed a lawsuit against OSI Pharmaceuticals for rejecting its tender offer, but will it work?
» MORE

FDA Halts Ranbaxy’s Generic Flomax
The Indian generic firm Ranbaxy was dealt another blow this week as its version of the enlarged prostate drug Flomax was denied approval in the US just as it was about to go to market
» MORE

PharmRep Direct Features

10 Things You Can Do to Add Value for Clients
Practical steps learned in the field to make sure you provide value to physicians and their offices
» MORE

Pharma Unplugged Episode #4: Give Until It Hurts
GAO reviews price hikes in branded drugs, FDA opens up to public, and pharma opens its wallet for Haiti are covered in this installment of the Pharma Unplugged podcast
» MORE

Pharmacists Expand Focus on Women's Health
As their growing role in healthcare causes pharmacists to focus more on medication management and patient consulting, some are specializing in healthcare issues and needs specific to women
» MORE


 
FindPharma   Search
 
Subscribe To PharmRep Today!
 
PharmRep Direct Quick Links
New law pushes mental health parity

Obama’s healthcare reform letter annotated

Shire takes aim at Genzyme


Follow Pharm Rep on Twitter



You are subscribed to %%list.name%% as %%emailaddr%%. To unsubscribe from this list click here.

To ensure delivery to your Inbox, please add %%email.list%% to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.

Visit PharmRep.com Today! Visit www.PharmRep.com Today!